Skip to main content
. 2020 Jun 23;64(7):e02584-19. doi: 10.1128/AAC.02584-19

TABLE 1.

Protein binding percentages across the study phases

Phasea Mean % protein binding (SD)b
Ceftriaxone Ertapenem
1 19.9 (3.7) B 40.6 (4.2) B
2 19.1 (6.0) C 42.8 (3.7) C
3 68.0 (2.3) 68.9 (2.3)
a

Phase 1, normoalbuminemia; phase 2, hypoalbuminemia; phase 3, albumin replacement.

b

B, significant difference (P < 0.05) between phases 1 and 3; C, significant difference (P < 0.05) between phases 2 and 3.